Metrics as of 10/16/2026, 10:48 PM (Berlin time), refresh in progress.
Neogen Stock
Neogen Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Mikhael Nassif
- Employees
- 2,636
- Market cap
- $2.6 B
- IPO
- 23/08/1989
Neogen Corporation is a global leader in the creation, manufacturing, and distribution of products essential for food quality and animal health. Founded in 1981, the company is headquartered in Lansing, USA, and operates within the Healthcare sector as part of the Medical - Devices industry. The enterprise is…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Neogen stock: price history
1D
-3.7%
1W
-0.3%
1M
-5.9%
6M
+24.2%
YTD
+69.0%
1Y
+99.2%
2Y
-19.2%
5Y
-71.2%
10Y
-40.1%
Next earnings date
Next earnings date
14/01/2027 (in 89 days)
Volatility around earnings
~132% stronger price swings than usual
Neogen stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
1 more assignment (Enabler/Second row) Pro-only.
Neogen Corporation is a globally operating company specialized in food safety and animal health. The business model is divided into two segments: Food Safety and Animal Safety. In the Food Safety segment, the company offers diagnostic test kits for identifying contaminants such as pathogens, toxins, or allergens, as well as solutions for hygiene monitoring. The Animal Safety segment encompasses a broad spectrum ranging from veterinary instruments to pharmaceuticals and vaccines, along with specialized genomics testing services. The revenue model is predominantly driven by product sales (88.3%), while services account for 11.7% of revenue. The customer base comprises a diverse range of food producers, agricultural operations, laboratories, and pharmaceutical companies.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- None
- Moat type
- None
- Capital intensity
- Low
- Customer concentration
- Low
Ask the agents about Neogen
Analyst assessment of Neogen
PRICE TARGET LOW
US$13.00
CONSENSUS
US$13.50
MEDIAN
US$13.50
PRICE TARGET HIGH
US$14.00
0
STRONG BUY
5
BUY
5
HOLD
1
SELL
0
STRONG SELL
11
TOTAL · Buy
As of: 30/09/2026
Neogen stock metrics
P/E
-46.64
P/B
1.23
EV/EBITDA
30.25
RETURN ON EQUITY
-0.6%
NET MARGIN
-5.3%
DEBT/EQUITY
0.37
DIVIDEND YIELD
0.0%
AS OF
31/08/2026
Free float & liquidity
FREE FLOAT
99.0%
FLOAT SHARES
216,153,939
AVG. DAILY VOLUME (30D)
4,668,275
Insider transactions (SEC)
Nassif Mikheal
RODRIGUEZ RAFAEL A
Wainer Andrea F
Green Ronald D
BOREL JAMES C
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Neogen stock
What does Neogen do?
Neogen Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Mikhael Nassif, the company employs around 2,636 people.
The IPO was on 23/08/1989; the stock trades on NASDAQ under the ticker NEOG.
What do analysts say about Neogen stock?
11 analysts rate the stock, the consensus is Buy (as of 30/09/2026).
The average price target is US$13.50, ranging from US$13.00 to US$14.00, with a median of US$13.50.
This is an external assessment, not a statement by Market Jury.
When does Neogen report next?
The next earnings date is 14/01/2027.
Around past earnings, price swings were roughly 132% stronger than usual.
Does Neogen pay a dividend?
No, Neogen currently does not pay a dividend.
Which stocks are comparable to Neogen?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Neogen stock analyzed?
Clicking "Analyze stock" lets five strategies assess Neogen against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.